These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 14660992

  • 1. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 2. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H, Isbir T, Agachan B, Karaali ZE.
    Cell Biochem Funct; 2005 Dec; 23(1):23-8. PubMed ID: 15386541
    [Abstract] [Full Text] [Related]

  • 3. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ.
    N Engl J Med; 1998 Jan 08; 338(2):86-93. PubMed ID: 9420339
    [Abstract] [Full Text] [Related]

  • 4. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, Smelt AH.
    Eur J Hum Genet; 2005 Jul 08; 13(7):877-82. PubMed ID: 15856070
    [Abstract] [Full Text] [Related]

  • 5. Cholesteryl ester-transfer protein (CETP) polymorphism and the association of acute coronary syndromes by obesity status in Greek subjects: the CARDIO2000-GENE study.
    Dedoussis GV, Panagiotakos DB, Louizou E, Mantoglou I, Chrysohoou C, Lamnisou K, Pitsavos C, Stefanadis C.
    Hum Hered; 2007 Jul 08; 63(3-4):155-61. PubMed ID: 17310124
    [Abstract] [Full Text] [Related]

  • 6. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):854-7. PubMed ID: 14998629
    [Abstract] [Full Text] [Related]

  • 7. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ, Zhang SZ, He Y, Zhang L, Zhang KL, Huang DJ, Sun Y.
    Chin Med J (Engl); 2004 Sep 03; 117(9):1288-92. PubMed ID: 15377415
    [Abstract] [Full Text] [Related]

  • 8. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
    Yilmaz H, Agachan B, Karaali ZE, Isbir T.
    Int J Mol Med; 2004 Jun 03; 13(6):889-93. PubMed ID: 15138631
    [Abstract] [Full Text] [Related]

  • 9. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P, Mensink RP, Hornstra G.
    Nutr Metab Cardiovasc Dis; 2002 Dec 03; 12(6):317-24. PubMed ID: 12669678
    [Abstract] [Full Text] [Related]

  • 10. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.
    Circulation; 2005 Jan 25; 111(3):278-87. PubMed ID: 15655129
    [Abstract] [Full Text] [Related]

  • 11. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.
    Z Kardiol; 2004 Jan 25; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [Abstract] [Full Text] [Related]

  • 12. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
    Marschang P, Sandhofer A, Ritsch A, Fiŝer I, Kvas E, Patsch JR.
    J Intern Med; 2006 Aug 25; 260(2):151-9. PubMed ID: 16882279
    [Abstract] [Full Text] [Related]

  • 13. CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.
    Regieli JJ, Jukema JW, Grobbee DE, Kastelein JJ, Kuivenhoven JA, Zwinderman AH, van der Graaf Y, Bots ML, Doevendans PA.
    Eur Heart J; 2008 Nov 25; 29(22):2792-9. PubMed ID: 18957472
    [Abstract] [Full Text] [Related]

  • 14. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
    Hodoğlugil U, Williamson DW, Huang Y, Mahley RW.
    Clin Genet; 2005 Aug 25; 68(2):118-27. PubMed ID: 15996208
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholesteryl ester transfer protein TAQ1B polymorphism in renal transplant patients.
    Zeybek U, Isbir T, Ergen HA, Yilmaz H, Hekim N, Akoglu E.
    Transplant Proc; 2006 Jun 25; 38(5):1382-4. PubMed ID: 16797310
    [Abstract] [Full Text] [Related]

  • 16. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R, Galvan G, Malaimare L, Derflinger I, Hedegger M, Lang J, Iglseder B, Ladurner G, Paulweber B.
    Biomed Pharmacother; 2004 Dec 25; 58(10):619-27. PubMed ID: 15589073
    [Abstract] [Full Text] [Related]

  • 17. Variations in high-density lipoprotein cholesterol in relation to physical activity and Taq 1B polymorphism of the cholesteryl ester transfer protein gene.
    Mukherjee M, Shetty KR.
    Clin Genet; 2004 May 25; 65(5):412-8. PubMed ID: 15099350
    [Abstract] [Full Text] [Related]

  • 18. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
    Khera AV, Wolfe ML, Cannon CP, Qin J, Rader DJ.
    Am J Cardiol; 2010 Aug 15; 106(4):451-6. PubMed ID: 20691300
    [Abstract] [Full Text] [Related]

  • 19. Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in Saudis.
    Al-Daghri NM, Al-Attas O, Patel A, Belyaev ND, Bartlett WA, Jones AF, Kumar S, Bain SC.
    Clin Sci (Lond); 2003 Oct 15; 105(4):467-72. PubMed ID: 12773093
    [Abstract] [Full Text] [Related]

  • 20. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
    Liu J, Zhao D, Liu S, Liu J, Qin LP, Wu ZS.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr 15; 24(4):300-3. PubMed ID: 12820950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.